Cargando…
Obstetric Management of COVID-19 in Pregnant Women
The 2019 novel coronavirus disease (COVID-19), which is caused by the novel beta coronavirus, SARS-CoV-2, is currently prevalent all over the world, causing thousands of deaths with relatively high virulence. Like two other notable beta coronaviruses, severe acute respiratory syndrome coronavirus-1...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264107/ https://www.ncbi.nlm.nih.gov/pubmed/32574255 http://dx.doi.org/10.3389/fmicb.2020.01186 |
_version_ | 1783540902883491840 |
---|---|
author | Mei, Youwen Luo, Dan Wei, Sumei Liao, Xiaoyan Pan, Yue Yang, Xiao Lin, Yonghong |
author_facet | Mei, Youwen Luo, Dan Wei, Sumei Liao, Xiaoyan Pan, Yue Yang, Xiao Lin, Yonghong |
author_sort | Mei, Youwen |
collection | PubMed |
description | The 2019 novel coronavirus disease (COVID-19), which is caused by the novel beta coronavirus, SARS-CoV-2, is currently prevalent all over the world, causing thousands of deaths with relatively high virulence. Like two other notable beta coronaviruses, severe acute respiratory syndrome coronavirus-1 (SARS-CoV-1) and Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2 can lead to severe contagious respiratory disease. Due to impaired cellular immunity and physiological changes, pregnant women are susceptible to respiratory disease and are more likely to develop severe pneumonia. Given the prevalence of COVID-19, it is speculated that some pregnant women have already been infected. However, limited data are available for the clinical course and management of COVID-19 in pregnancy. Therefore, we conducted this review to identify strategies for the obstetric management of COVID-19. We compared the clinical course and outcomes of COVID-19, SARS, and MERS in pregnancy and discussed several drugs for the treatment of COVID-19 in pregnancy. |
format | Online Article Text |
id | pubmed-7264107 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72641072020-06-10 Obstetric Management of COVID-19 in Pregnant Women Mei, Youwen Luo, Dan Wei, Sumei Liao, Xiaoyan Pan, Yue Yang, Xiao Lin, Yonghong Front Microbiol Microbiology The 2019 novel coronavirus disease (COVID-19), which is caused by the novel beta coronavirus, SARS-CoV-2, is currently prevalent all over the world, causing thousands of deaths with relatively high virulence. Like two other notable beta coronaviruses, severe acute respiratory syndrome coronavirus-1 (SARS-CoV-1) and Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2 can lead to severe contagious respiratory disease. Due to impaired cellular immunity and physiological changes, pregnant women are susceptible to respiratory disease and are more likely to develop severe pneumonia. Given the prevalence of COVID-19, it is speculated that some pregnant women have already been infected. However, limited data are available for the clinical course and management of COVID-19 in pregnancy. Therefore, we conducted this review to identify strategies for the obstetric management of COVID-19. We compared the clinical course and outcomes of COVID-19, SARS, and MERS in pregnancy and discussed several drugs for the treatment of COVID-19 in pregnancy. Frontiers Media S.A. 2020-05-26 /pmc/articles/PMC7264107/ /pubmed/32574255 http://dx.doi.org/10.3389/fmicb.2020.01186 Text en Copyright © 2020 Mei, Luo, Wei, Liao, Pan, Yang and Lin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Mei, Youwen Luo, Dan Wei, Sumei Liao, Xiaoyan Pan, Yue Yang, Xiao Lin, Yonghong Obstetric Management of COVID-19 in Pregnant Women |
title | Obstetric Management of COVID-19 in Pregnant Women |
title_full | Obstetric Management of COVID-19 in Pregnant Women |
title_fullStr | Obstetric Management of COVID-19 in Pregnant Women |
title_full_unstemmed | Obstetric Management of COVID-19 in Pregnant Women |
title_short | Obstetric Management of COVID-19 in Pregnant Women |
title_sort | obstetric management of covid-19 in pregnant women |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264107/ https://www.ncbi.nlm.nih.gov/pubmed/32574255 http://dx.doi.org/10.3389/fmicb.2020.01186 |
work_keys_str_mv | AT meiyouwen obstetricmanagementofcovid19inpregnantwomen AT luodan obstetricmanagementofcovid19inpregnantwomen AT weisumei obstetricmanagementofcovid19inpregnantwomen AT liaoxiaoyan obstetricmanagementofcovid19inpregnantwomen AT panyue obstetricmanagementofcovid19inpregnantwomen AT yangxiao obstetricmanagementofcovid19inpregnantwomen AT linyonghong obstetricmanagementofcovid19inpregnantwomen |